Main
>
ONCOLOGY (**)
>
GEJ Cancer MET or R PD-L1+ ***
>
Treatment
>
USA. M. PembrolizuMAb>>
>
(*) USA Approval Date: 2017. 09.22
(*) USA Approval Date: 2017. 09.22's products
This section has no products